Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 10 studies | 45% ± 24% | |
| interneuron | 5 studies | 45% ± 22% | |
| GABAergic neuron | 5 studies | 51% ± 19% | |
| granule cell | 4 studies | 42% ± 17% | |
| neuron | 3 studies | 23% ± 3% | |
| endothelial cell | 3 studies | 46% ± 13% | |
| GABAergic interneuron | 3 studies | 24% ± 3% | |
| oligodendrocyte precursor cell | 3 studies | 26% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 9 studies | 34% ± 23% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 8324.92 | 2635 / 2642 | 100% | 48.29 | 702 / 705 |
| prostate | 92% | 807.41 | 225 / 245 | 93% | 65.17 | 467 / 502 |
| thymus | 95% | 981.35 | 623 / 653 | 47% | 4.60 | 283 / 605 |
| kidney | 100% | 2513.79 | 89 / 89 | 25% | 2.04 | 222 / 901 |
| ovary | 63% | 343.68 | 114 / 180 | 54% | 9.24 | 234 / 430 |
| adrenal gland | 67% | 450.39 | 174 / 258 | 39% | 3.09 | 90 / 230 |
| ureter | 0% | 0 | 0 / 0 | 100% | 4.75 | 1 / 1 |
| lung | 71% | 442.29 | 412 / 578 | 18% | 2.43 | 209 / 1155 |
| breast | 65% | 410.78 | 299 / 459 | 17% | 1.52 | 187 / 1118 |
| stomach | 66% | 443.43 | 237 / 359 | 6% | 0.49 | 17 / 286 |
| liver | 52% | 297.87 | 117 / 226 | 14% | 1.84 | 56 / 406 |
| bladder | 43% | 206.33 | 9 / 21 | 18% | 2.03 | 90 / 504 |
| intestine | 54% | 381.86 | 523 / 966 | 5% | 0.56 | 27 / 527 |
| uterus | 35% | 190.56 | 59 / 170 | 24% | 8.25 | 112 / 459 |
| blood vessel | 56% | 297.92 | 753 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 51% | 300.55 | 613 / 1204 | 0% | 0 | 0 / 0 |
| esophagus | 36% | 223.54 | 517 / 1445 | 3% | 0.13 | 5 / 183 |
| pancreas | 13% | 57.84 | 41 / 328 | 13% | 0.85 | 24 / 178 |
| skin | 20% | 90.33 | 369 / 1809 | 4% | 0.29 | 21 / 472 |
| heart | 16% | 62.65 | 135 / 861 | 0% | 0 | 0 / 0 |
| spleen | 13% | 76.11 | 32 / 241 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 13% | 1.05 | 10 / 80 |
| muscle | 7% | 31.59 | 58 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| GO_0051480 | Biological process | regulation of cytosolic calcium ion concentration |
| GO_0045671 | Biological process | negative regulation of osteoclast differentiation |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| Gene name | TMEM178A |
| Protein name | Transmembrane protein 178A |
| Synonyms | TMEM178 UNQ5926/PRO19820 PSEC0131 |
| Description | FUNCTION: Acts as a negative regulator of osteoclast differentiation in basal and inflammatory conditions by regulating TNFSF11-induced Ca (2+) fluxes, thereby controlling the induction of NFATC1. . |
| Accessions | Q8NBL3 ENST00000281961.3 [Q8NBL3-1] |